Hopital Europeen Georges Pompidou Begins Clinical Evaluation of BioCurex Cancer Detection Kits
23 oct. 2003 08h00 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., Oct. 23, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) is pleased to announce that extensive evaluations of the company's RECAF(tm) cancer detection technologies have...
Breast Cancer Awareness and BioCurex Inc.
22 oct. 2003 17h11 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., Oct. 22, 2003 (PRIMEZONE) -- Biocurex Inc. (OTCBB:BOCX) is developing basic techniques using its patented technology that could be applied effectively to assist the...
Biocurex Reports Results on Blood Test for Ovarian Cancer with a Market Potential of $200 Million Dollars; Test Outperforms Current Reference Assay
18 juin 2003 16h21 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., June 18, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces an estimate of 25% penetration of this $200 million market within the next 3 years via licensing...
BioCurex Starts Clinical Evaluation of Its Cancer Detections Kits With Research Centers And Hospitals In Japan
03 juin 2003 17h01 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., June 3, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that it has started an evaluation of the company's RECAF(TM) based cancer detection kits in Japan....
BioCurex Announces New Blood Test For Cancer Detection with 95% Sensitivity, 95% Specificity - Addressing a $2 Billion Market
28 mai 2003 16h55 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., May 28, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces initial results for its Serum-RECAF(TM) cancer test. A universal cancer marker can be used not only...
Biocurex Announces Appointment of New CEO
01 mai 2003 16h19 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., May 1, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that its Board of Directors has appointed Dr. Ricardo Moro-Vidal as Chief Executive Officer of the...
BioCurex Inc.: Introduction of the FDA Cleared Histo-RECAF Technology to Major Drug Companies and Professionals
28 avr. 2003 16h01 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., April 28, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announces that the prestigious trade journal IVD Technology (In-vitro Diagnostic Technology) has invited...
BioCurex Announces BioLargo Technologies Inc. Joint Venture with Cryopak Industries Inc.
04 avr. 2003 07h00 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., April 4, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) today announced that BioLargo technologies Inc. has negotiated a joint venture marketing agreement with Cryopak...
BioCurex Announces BioLargo Technologies Inc. Joint Venture with Cryopak Industries Inc.
03 avr. 2003 16h34 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., April 3, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) today announced that BioLargo technologies Inc. has negotiated a joint venture marketing agreement with Cryopak...
BioCurex Announces a Proposed 3 for 1 Forward Split
13 mars 2003 10h30 HE
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., March 13, 2003 (PRIMEZONE) -- BioCurex Inc. (OTCBB:BOCX) announced today that its Board of Directors unanimously voted to submit to the Company's shareholders a...